We are live on ! Find out more
JC

JBF Capital Portfolio holdings

AUM $764M
1-Year Est. Return 24.26%
This Fund
S&P 500
This Quarter Est. Return
+8.53%
1 Year Est. Return
+24.26%
3 Year Est. Return
+93.63%
5 Year Est. Return
+127.41%
10 Year Est. Return
+469.69%
AUM
$706M
AUM Growth
+$78M
Cap. Flow
+$32.1M
Cap. Flow %
4.55%
Top 10 Hldgs %
86%
Holding
88
New
22
Increased
4
Reduced
9
Closed
10

Top Sells

Rank Stock Value
1
IBIT icon
iShares Bitcoin Trust
IBIT
+$5.33M
2
VST icon
Vistra
VST
+$4.85M
3
ICAD
iCAD Inc
ICAD
+$686K
4
VIGL
Vigil Neuroscience
VIGL
+$557K
5
INBX icon
Inhibrx
INBX
+$299K

Sector Composition

Rank Sector Weight
1 Miscellaneous 50.42%
2 Technology 17.55%
3 Consumer Discretionary 15.45%
4 Communication Services 7.98%
5 Financials 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVLU icon
26
iShares MSCI Intl Value Factor ETF
IVLU
$4.68B
$2.13M 0.3%
60,000
CRH icon
27
CRH
CRH
$61.2B
$1.8M 0.25%
15,000
MU icon
28
Micron Technology
MU
$1.08T
$1.67M 0.24%
10,000
JPM icon
29
JPMorgan Chase
JPM
$962B
$1.58M 0.22%
5,000
XBI icon
30
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$1.5M 0.21%
+15,000
New +$1.35M
LU icon
31
Lufax Holding
LU
$1.07B
$1.38M 0.2%
339,884
SYF icon
32
Synchrony
SYF
$26B
$1.28M 0.18%
18,000
-1,000
-5% -$72.5K
SF
33
Stifel
SF
$12.4B
$1.13M 0.16%
15,000
LAUR icon
34
Laureate Education
LAUR
$4.95B
$1.1M 0.16%
35,000
GLUE icon
35
Monte Rosa Therapeutics
GLUE
$1.23B
$1.1M 0.16%
+148,566
New +$787K
PSNL icon
36
Personalis
PSNL
$1.8B
$1.08M 0.15%
+166,104
New +$945K
PRME icon
37
Prime Medicine
PRME
$673M
$1.05M 0.15%
+188,900
New +$767K
TWST icon
38
Twist Bioscience
TWST
$8.47B
$1.04M 0.15%
+37,100
New +$1.12M
ARKG icon
39
ARK Genomic Revolution ETF
ARKG
$2B
$1.03M 0.15%
+37,200
New +$940K
FSLR icon
40
First Solar
FSLR
$22.3B
$1M 0.14%
+4,551
New +$874K
LAB icon
41
Standard BioTools
LAB
$265M
$1M 0.14%
+770,654
New +$1.01M
NLOP
42
Net Lease Office Properties
NLOP
$165M
$956K 0.14%
32,228
GTLB icon
43
GitLab
GTLB
$8.22B
$956K 0.14%
+21,200
New +$970K
BBVA icon
44
Banco Bilbao Vizcaya Argentaria
BBVA
$164B
$837K 0.12%
43,500
-5,000
-10% -$87.4K
XPO icon
45
XPO
XPO
$21.6B
$776K 0.11%
6,000
SCPH
46
DELISTED
scPharmaceuticals
SCPH
$765K 0.11%
+135,000
New +$691K
LWAY icon
47
Lifeway Foods
LWAY
$388M
$763K 0.11%
27,500
COF icon
48
Capital One
COF
$135B
$744K 0.11%
3,500
-500
-13% -$109K
ETNB
49
DELISTED
89bio
ETNB
$735K 0.1%
+50,000
New +$510K
PBR icon
50
Petrobras
PBR
$132B
$709K 0.1%
60,000
+10,000
+20% +$126K

Similar funds

JBF Capital's Q3 2025 Portfolio in Review

As of Q3 2025, JBF Capital held 88 positions worth $706M, up 12% from $628M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

JBF Capital deployed $32.1M of net new capital in Q3 2025, opening 22 new positions and adding to 4 existing holdings. Its largest new stake was iPath Series B S&P 500 VIX Short-Term Futures ETN: 108,000 shares worth $3.58M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 52% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was AerCap, an estimated $175K trimmed.

  • JBF Capital's largest Q3 2025 buy was iPath Series B S&P 500 VIX Short-Term Futures ETN: 108,000 shares worth $3.58M.
  • JBF Capital added most to Alphabet (Google) Class A in Q3 2025, an estimated $16.1M increase.
  • JBF Capital's biggest Q3 2025 reduction was AerCap, cutting an estimated $175K.
  • JBF Capital fully exited iShares Bitcoin Trust in Q3 2025, selling an estimated $5.33M.
  • JBF Capital's ten largest holdings make up 86% of its $706M portfolio in Q3 2025.
  • JBF Capital opened 22 new positions and closed 10 in Q3 2025.
  • JBF Capital's portfolio value rose 12% quarter-over-quarter to $706M.

Based on JBF Capital's 13F filing for Q3 2025, filed 13 Nov 2025.